Literature DB >> 8206588

Epidermal growth factor-enhanced human angiotensin II type 1 receptor.

D F Guo1, T Inagami.   

Abstract

The human angiotensin II type 1 (AT1) receptor gene was isolated and its promoter function analyzed by deletion mutant promoter/luciferase constructs in transfected Cos 7 cells. We found that epidermal growth factor enhanced the human AT1 promoter activity twofold to threefold. The region between -227 and -366 bp from the 5' end of the cDNA was mapped for a base sequence responsive to the epidermal growth factor stimulation. By computer analysis, PEA3 transcription factor was located in this region and was shown to bind to the promoter by gel shift assay in Cos 7 and HepG2 cells. These results indicated that the human AT1 receptor enhanced by epidermal growth factor may be due to PEA3 binding to the human AT1 promoter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206588     DOI: 10.1161/01.hyp.23.6.1032

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  4 in total

Review 1.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

Review 2.  Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide.

Authors:  Jing Zheng; Ian M Bird; Dong-Bao Chen; Ronald R Magness
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

3.  Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats.

Authors:  L Feng; G E Garcia; Y Yang; Y Xia; F B Gabbai; O W Peterson; J A Abraham; R C Blantz; C B Wilson
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 4.  Subtype 2 and atypical angiotensin receptors in the human heart.

Authors:  V Regitz-Zagrosek; M Neuss; C Warnecke; J Holzmeister; A G Hildebrandt; E Fleck
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.